Adjuvant and first-line palliative chemotherapy regimens in patients diagnosed with periampullary cancer: a short report from a nationwide registry

Authors

  • Evelien J. M. de Jong Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Center, GROW, Maastricht University, Maastricht, the Netherlands
  • Irene Mommers Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Center, GROW, Maastricht University, Maastricht, the Netherlands
  • Arantza Fariña Sarasqueta Department of Pathology, Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, the Netherlands
  • Lydia G. van der Geest Department of Research and Innovation, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands
  • Lara Heij Department of Surgery, School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands; Department of General, Gastrointestinal, Hepatobiliary and Transplant Surgery, RWTH Aachen University Hospital, Aachen, Germany; Institute of Pathology, RWTH Aachen University, Aachen, Germany
  • Ignace H. J. T. de Hingh Department of Surgery, Catharina Cancer Institute, Eindhoven, the Netherlands; GROW, Maastricht University, Maastricht, the Netherlands
  • Marjolein Y. V. Homs Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands
  • Vivianne C. G. Tjan-Heijnen Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Center, GROW, Maastricht University, Maastricht, the Netherlands
  • Liselot B. J. Valkenburg-van Iersel Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Center, GROW, Maastricht University, Maastricht, the Netherlands
  • Johanna W. Wilmink Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, the Netherlands
  • Sandra M. E. Geurts Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Center, GROW, Maastricht University, Maastricht, the Netherlands
  • Judith de Vos-Geelen Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Center, GROW, Maastricht University, Maastricht, the Netherlands

DOI:

https://doi.org/10.1080/0284186X.2022.2053199

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2022-05-04

How to Cite

de Jong, E. J. M., Mommers, I., Fariña Sarasqueta, A., van der Geest, L. G. ., Heij, L., de Hingh, I. H. J. T., … de Vos-Geelen, J. (2022). Adjuvant and first-line palliative chemotherapy regimens in patients diagnosed with periampullary cancer: a short report from a nationwide registry. Acta Oncologica, 61(5), 591–596. https://doi.org/10.1080/0284186X.2022.2053199

Issue

Vol. 61 No. 5 (2022): Acta Oncologica

Section

Articles